IBM cases had significantly more CD4+ cells compared to all dystrophy cases and controls (p ≤ 0.003) and significantly more CD8+ cells compared to all other diagnoses including dermatomyositis cases (p ≤ 0.006). This evidence concerns the gene CD4 and inclusion body myositis.